U.S. Markets closed

Glucose Monitoring Device in Focus as Abbott Preps to Unveil Earnings

Armie Margaret Lee

Abbott's Freestyle Libre in September secured FDA approval and in January, the company said the device had received reimbursement from the Centers for Medicare & Medicaid Services.